| # | Drug | Count |
|---|---|---|
| 0 | MYCOPHENOLATE MOFETIL | 166 |
| 1 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 166 |
| 2 | PREDNISONE | 145 |
| 3 | METHOTREXATE SODIUM | 142 |
| 4 | METHOTREXATE | 122 |
| 5 | TACROLIMUS | 108 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 100 |
| 7 | TACROLIMUS OINTMENT 0.1% | 100 |
| 8 | PREDNISOLONE | 99 |
| 9 | PREDNISOLONE ORAL | 99 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SELADELPAR LYSINE | 1 | 0.0036 |
| 1 | IDARUBICIN HYDROCHLORIDE | 4 | 0.0035 |
| 2 | PRALATREXATE | 2 | 0.0031 |
| 3 | MEGNESIUM OXIDE | 1 | 0.0024 |
| 4 | CLOFARABINE | 5 | 0.0022 |
| 5 | FLUCYTOSINE | 3 | 0.0021 |
| 6 | ALEMTUZUMAB | 36 | 0.0019 |
| 7 | MECHLORETHAMINE HYDROCHLORIDE | 4 | 0.0018 |
| 8 | PYRIMETHAMINE | 2 | 0.0016 |
| 9 | BASILIXIMAB | 16 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 299 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 124 |
| 2 | Alkylating Drug [EPC] | 109 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 92 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 89 |
| 5 | Purine Antimetabolite [EPC] | 79 |
| 6 | Calcineurin Inhibitor Immunosuppressant [EPC] | 56 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 36 |
| 8 | Kinase Inhibitor [EPC] | 35 |
| 9 | Azole Antifungal [EPC] | 33 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 14 | 0.0024 |
| 1 | Nucleoside Analog Antifungal [EPC] | 3 | 0.0021 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 36 | 0.0019 |
| 3 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 2 | 0.0016 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 26 | 0.0012 |
| 5 | Purine Antimetabolite [EPC] | 79 | 0.0008 |
| 6 | CD30-directed Immunoconjugate [EPC] | 8 | 0.0008 |
| 7 | Selective T Cell Costimulation Blocker [EPC] | 3 | 0.0006 |
| 8 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 14 | 0.0006 |
| 9 | Histone Deacetylase Inhibitor [EPC] | 2 | 0.0005 |